The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
To own Olin today, you need to be comfortable with a cyclical, currently unprofitable chemicals and ammunition business that is working through earnings pressure and end‑market weakness. The new US$95.4 million ESOP‑related shelf registration and ongoing dividend do not materially change the near‑term picture, where soft chlor‑alkali fundamentals and ammunition margin pressure remain the key catalyst and risk to watch in the short run.
Among recent announcements, the repeated affirmation of a US$0.2000 quarterly dividend stands out alongside the ESOP filing. Together, they underline that Olin is still committing cash to shareholders even after reporting a net loss of US$96.3 million for the first half of 2026. How effectively the company can support that dividend while addressing leverage and funding needs will matter for how investors weigh income against balance sheet risk.
But against that backdrop, you should also be aware that...
Read the full narrative on Olin (it's free!)
Olin's narrative projects $7.7 billion revenue and $244.3 million earnings by 2029. This requires 4.8% yearly revenue growth and a $441.2 million earnings increase from -$196.9 million today.
Uncover how Olin's forecasts yield a $22.38 fair value, a 18% upside to its current price.
Compared with the baseline, the most bearish analysts built in only 2.7% annual revenue growth and US$72.3 million of earnings by 2029, so this ESOP‑linked shelf could yet test how comfortable you are with such a cautious view.
Explore 5 other fair value estimates on Olin - why the stock might be worth just $22.38!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com